The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Treatment-Induced Pathologic Necrosis: A Predictor of Local Recurrence and Survival in Patients Receiving Neoadjuvant Therapy for High-Grade Extremity Soft Tissue Sarcomas
Abstract
PURPOSE: To determine whether treatment-induced pathologic necrosis correlates with local recurrence and overall survival in patients who receive neoadjuvant therapy for high-grade extremity soft tissue sarcomas. PATIENTS AND METHODS: Four hundred ninety-six patients with intermediate- to high-grade extremity soft tissue sarcomas received protocol neoadjuvant therapy. All patients underwent surgical resection after neoadjuvant therapy and had pathologic assessment of tumor necrosis in the resected specimens. RESULTS: The 5- and 10-year local recurrence rates for patients with ≥ 95% pathologic necrosis were significantly lower (6% and 11%, respectively) than the local recurrence rates for patients with less than 95% pathologic necrosis (17% and 23%, respectively). The 5- and 10-year survival rates for the patients with ≥ 95% pathologic necrosis were significantly higher (80% and 71%, respectively) than the survival rates for the patients with less than 95% pathologic necrosis (62% and 55%, respectively). Patients with less than 95% pathologic necrosis were 2.51 times more likely to develop a local recurrence and 1.86 times more likely to die of their disease as compared with patients with ≥ 95% pathologic necrosis. The percentage of patients who achieved ≥ 95% pathologic necrosis increased to 48% with the addition of ifosfamide as compared with 13% of the patients in all the other protocols combined. CONCLUSION: Treatment-induced pathologic necrosis is an independent predictor of both local recurrence and overall survival in patients who receive neoadjuvant therapy for high-grade extremity soft tissue sarcomas. A complete pathologic response (≥ 95% pathologic necrosis) correlated with a significantly lower rate of local recurrence and improved overall survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pisters, P. W., Leung, D. H., Woodruff, J., Shi, W., & Brennan, M. F. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1679 · Cited by 1,220
Rosen, G., Caparros, B., Huvos, A. G., Kosloff, C., Nirenberg, A., Cacavio, A., Marcove, R. C., Lane, J. M., Mehta, B., & Urban, C. (1982) · Cancer · doi:10.1002/1097-0142(19820315)49:6<1221::aid-cncr2820490625>3.0.co;2-e · Cited by 1,090
Self-citation(1997) · The Lancet · doi:10.1016/s0140-6736(97)08165-8 · Cited by 1,044
Coindre, J. M., Terrier, P., Bui, N. B., Bonichon, F., Collin, F., Le Doussal, V, Mandard, A. M., Vilain, M. O., Jacquemier, J., Duplay, H., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.869 · Cited by 636
WUNDER, J. S., PAULIAN, G., HUVOS, A. G., HELLER, G., MEYERS, P. A., & HEALEY, J. H. (1998) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199807000-00011 · Cited by 247
Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
Schulte, M., Brecht-Krauß, D., Werner, M., Hartwig, E., Sarkar, M. R., Keppler, P., Kotzerke, J., Guhlmann, A., Delling, G., & Reske, S. N. (1999) · PubMed · Cited by 198
Jones, D. N., McCowage, G. B., Sostman, H. D., Brizel, D. M., Layfield, L. J., Charles, H. C., Dewhirst, M. W., Prescott, D. M., Friedman, H. S., Harrelson, J. M., et al. (1996) · PubMed · Cited by 159
Multifactorial Analysis of Long-term Follow-up (More Than 5 Years) of Primary Extremity Sarcoma
Lewis, J. J. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.2.190 · Cited by 129
The role of the pathologist in the management of soft tissue sarcomas
Hajdu, S. I., Shiu, M. H., & Brennan, M. F. (1988) · World Journal of Surgery · doi:10.1007/bf01655665 · Cited by 98
Tumour volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma
Abudu, A., Davies, A. M., Pynsent, P. B., Mangham, D. C., Tillman, R. M., Carter, S. R., & Grimer, R. J. (1999) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.81b2.0810317 · Cited by 69
Cited by
Adam, R., Pascal, G., Castaing, D., Azoulay, D., Delvart, V., Paule, B., Levi, F., & Bismuth, H. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000145964.08365.01 · Cited by 1,001
Cormier, J. N., & Pollock, R. E. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.94 · Cited by 835
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2626 · Cited by 671
Bonvalot, S., Rutkowski, P. L., Thariat, J., Carrère, S., Ducassou, A., Sunyach, M.-P., Agoston, P., Hong, A., Mervoyer, A., Rastrelli, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30326-2 · Cited by 536
Allen, P. J., Kemeny, N., Jarnagin, W., DeMatteo, R., Blumgart, L., & Fong, Y. (2003) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(02)00121-x · Cited by 301
Metadata
- Authors
- Eilber, F. C., Rosen, G., Eckardt, J., Forscher, C., Nelson, S. D., Selch, M., Dorey, F., & Eilber, F. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-07-01
- Volume
- 19
- Issue
- 13
- Pages
- 3203-3209
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1907859928
- Cited by
- 329
- References
- 13
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment-Induced Pathologic Necrosis: A Predictor of Local Recurrence and Survival in Patients Receiving Neoadjuvant Therapy for High-Grade Extremity Soft Tissue Sarcomas. https://app.cochat.ai/papers/10.1200/jco.2001.19.13.3203
- The paper
- Eilber, F. C., Rosen, G., Eckardt, J., Forscher, C., Nelson, S. D., Selch, M., Dorey, F., & Eilber, F. R. (2001). Treatment-Induced Pathologic Necrosis: A Predictor of Local Recurrence and Survival in Patients Receiving Neoadjuvant Therapy for High-Grade Extremity Soft Tissue Sarcomas. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2001.19.13.3203
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.